Jeong Heo

机构：Pusan National University Hospital, Pusan National University · ORCID：0000-0003-0961-7851

发表论文 364 篇 · 总被引 10703 次 · h-index 48

代表论文

• Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial (2025 · Nature Medicine · 被引 12)
• Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection (2026 · New England Journal of Medicine · 被引 7)
• A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma. (2025 · Journal of Clinical Oncology · 被引 7)
• GS-010 Outcomes of 48 weeks of therapy and subsequent 24-week post-treatment period with tobevibart (VIR-3434) and elebsiran (VIR-2218) with or without pegylated interferon alfa-2a in chronic hepatitis B virus infection. Findings from the MARCH study (2025 · Journal of Hepatology · 被引 6)
• Lactic Acid Bacteria as Probiotics Improve Bioactive Compounds in Radix Angelica gigas (Danggui) via Solid-State Fermentation (2025 · Fermentation · 被引 5)
• Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives (2026 · Vaccines · 被引 4)